| Primary |
| Nausea |
18.1% |
| Prophylaxis Of Nausea And Vomiting |
18.1% |
| Drug Use For Unknown Indication |
17.1% |
| Product Used For Unknown Indication |
11.3% |
| Vomiting |
7.2% |
| Premedication |
4.8% |
| Chemotherapy |
4.1% |
| Hyperemesis Gravidarum |
2.8% |
| Prophylaxis |
2.5% |
| Breast Cancer |
2.4% |
| Hypertension |
1.8% |
| Depression |
1.5% |
| Pain |
1.5% |
| Drug Exposure During Pregnancy |
1.4% |
| Non-small Cell Lung Cancer |
1.4% |
| Colon Cancer |
1.0% |
| Acute Myeloid Leukaemia |
0.9% |
| Neoplasm Malignant |
0.7% |
| Antiemetic Supportive Care |
0.7% |
| Bronchitis |
0.6% |
|
| Vomiting |
18.5% |
| Death |
15.5% |
| Drug Ineffective |
14.0% |
| Nausea |
7.9% |
| Drug Exposure During Pregnancy |
7.0% |
| Urticaria |
3.4% |
| Neoplasm Malignant |
3.0% |
| Constipation |
2.6% |
| Rash Papular |
2.6% |
| Weight Decreased |
2.6% |
| Disease Progression |
2.5% |
| Headache |
2.5% |
| Off Label Use |
2.5% |
| Tremor |
2.5% |
| Live Birth |
2.3% |
| Malaise |
2.3% |
| Pharmaceutical Product Complaint |
2.3% |
| Therapeutic Response Unexpected |
2.3% |
| Dizziness |
1.9% |
| Extrapyramidal Disorder |
1.9% |
|
| Secondary |
| Product Used For Unknown Indication |
28.1% |
| Nausea |
13.3% |
| Drug Use For Unknown Indication |
7.8% |
| Foetal Exposure During Pregnancy |
6.5% |
| Premedication |
6.0% |
| Breast Cancer |
5.9% |
| Vomiting |
5.7% |
| Prophylaxis |
3.7% |
| Pain |
3.3% |
| Prophylaxis Of Nausea And Vomiting |
2.6% |
| Depression |
2.2% |
| Acute Myeloid Leukaemia |
2.1% |
| Lymphoma |
2.0% |
| Chemotherapy |
2.0% |
| Hypertension |
1.8% |
| Chronic Lymphocytic Leukaemia |
1.6% |
| Constipation |
1.6% |
| Migraine |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Non-small Cell Lung Cancer |
1.3% |
|
| Vomiting |
19.1% |
| Nausea |
8.2% |
| Death |
6.0% |
| Premature Baby |
6.0% |
| Shock |
6.0% |
| Weight Decreased |
6.0% |
| Drug Hypersensitivity |
5.6% |
| White Blood Cell Count Decreased |
5.6% |
| Chills |
4.5% |
| Tremor |
4.1% |
| Malaise |
3.4% |
| Respiratory Distress |
3.4% |
| Vertigo |
3.4% |
| Dehydration |
3.0% |
| Pruritus |
3.0% |
| Chest Pain |
2.6% |
| Intra-uterine Death |
2.6% |
| Photosensitivity Reaction |
2.6% |
| Somnolence |
2.6% |
| Drug Ineffective |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.6% |
| Drug Use For Unknown Indication |
17.7% |
| Nausea |
8.9% |
| Pain |
7.3% |
| Prophylaxis |
3.6% |
| Hypertension |
3.2% |
| Non-small Cell Lung Cancer |
3.0% |
| Breast Cancer |
3.0% |
| Premedication |
2.9% |
| Multiple Myeloma |
2.8% |
| Vomiting |
2.7% |
| Constipation |
2.3% |
| Depression |
2.3% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Anxiety |
2.1% |
| Crohn's Disease |
1.8% |
| Abdominal Pain |
1.6% |
| Insomnia |
1.6% |
| Breast Cancer Metastatic |
1.2% |
| Asthma |
1.1% |
|
| Vomiting |
23.8% |
| Weight Decreased |
8.5% |
| White Blood Cell Count Decreased |
6.0% |
| Pulmonary Embolism |
5.6% |
| Pyrexia |
5.1% |
| Thrombocytopenia |
5.1% |
| Nausea |
5.1% |
| Death |
4.8% |
| Pneumonia |
3.9% |
| Pain |
3.8% |
| Urinary Tract Infection |
3.4% |
| Suicide Attempt |
3.3% |
| Sepsis |
3.0% |
| Renal Failure |
3.0% |
| Renal Failure Acute |
3.0% |
| Weight Increased |
2.8% |
| Neutropenia |
2.6% |
| Rash |
2.5% |
| Dehydration |
2.4% |
| Diarrhoea |
2.3% |
|
| Interacting |
| Lymphoma |
26.3% |
| Smoking Cessation Therapy |
10.5% |
| Cancer Pain |
7.9% |
| Product Used For Unknown Indication |
7.9% |
| Chronic Lymphocytic Leukaemia |
5.3% |
| Epilepsy |
5.3% |
| Acute Lymphocytic Leukaemia |
2.6% |
| Anaemia |
2.6% |
| Anxiety |
2.6% |
| Bacterial Infection |
2.6% |
| Bladder Transitional Cell Carcinoma |
2.6% |
| Chemotherapy |
2.6% |
| Constipation |
2.6% |
| Decreased Appetite |
2.6% |
| Haemoptysis |
2.6% |
| Hypertension |
2.6% |
| Pneumonia |
2.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.6% |
| Respiratory Failure |
2.6% |
| Tachycardia |
2.6% |
|
| Drug Level Decreased |
16.7% |
| Nausea |
16.7% |
| Electrocardiogram Qt Prolonged |
8.3% |
| Hallucination |
8.3% |
| Ileus |
8.3% |
| Nightmare |
8.3% |
| Postoperative Fever |
8.3% |
| Tachycardia |
8.3% |
| Tumour Lysis Syndrome |
8.3% |
| Vision Blurred |
8.3% |
|